Congratulations to 2 lab members who have retired from our group. Yun Wang and Ms Carmen White. Thanks for their dedication to work and teaching of new generation of researchers @jesslin23.bsky.social @giaconajohn.bsky.social
John Giacona, PhD, PA-C
@giaconajohn.bsky.social
Assistant Professor | Hypertension Specialist UT Southwestern Medical Center
Excellent overview in The Washington Post on the systemic impact of sustained hypertension — from LVH to CKD and cognitive decline. Kudos to Drs. @drwanpen.bsky.social , John B, and @jordybc.bsky.social for evidence base insight. 🔗 www.washingtonpost.com/wellness/202... #Hypertension #Cardiology
What high blood pressure does to your body
Hypertension can affect your mind, heart, eyes and more, often without causing any obvious symptoms at all.
washingtonpost.com
New analysis led by our PhD candidate @robynwei.bsky.social shows ⬇️ salt substitute use among US adults, Not good for BP. 🚫 real salt @giaconajohn.bsky.social @jesslin23.bsky.social @utswim.bsky.social @jongarinn.bsky.social ahajournals.org/doi/10.1161/...
Our new paper @jesslin23.bsky.social showing low accuracy when eyeballing BP log and more importantly may lead to failure to start or ⬆️BP meds in HTN. Thanks 🙏all faculty&trainees for helping us @utswim.bsky.social www.ahajournals.org/doi/full/10.... @robynwei.bsky.social @giaconajohn.bsky.social
Good HTN journal club today by @robynwei.bsky.social discuss effects of ultraprocessed food on cardiometabolic health @giaconajohn.bsky.social @hkkimphd.bsky.social Need to eat less UPF! www.nature.com/articles/s41...
great HTN JC discussion today on BAXHTN study by Dr. Shawna Nesbitt joined by @dramitkhera.bsky.social @giaconajohn.bsky.social @utswim.bsky.social Interesting that baseline aldosterone in the trial was around 7.5 ng/dL by LCMS with baseline PRA is 1 ng/mlhr. This means that majority of pts have PA
🏆 First time at Epic Cosmos Datathon—our team took 1st place! Grateful for the collaboration and hands on experience ! @drwanpen.bsky.social Excited to present tomorrow (Oct 3) at Pegasus Park Symposium on “Missed Opportunities: Screening for Primary Aldosteronism” #EpicCosmos #HTN
Excellent commmentary from @giaconajohn.bsky.social and @drwanpen.bsky.social
Comparing Management strategies for Primary Aldosteronism: Is it 🍎 versus 🍊 ? Commentary academic.oup.com/ajh/article-... based on academic.oup.com/ajh/article-... #Hypertension #Aldosteronism
Optimal Treatment of Primary Aldosteronism: Can We Compare Apples to Oranges?
Primary aldosteronism (PA) is an endocrine disorder characterized by inappropriate and excessive aldosterone production.1 PA is a prevalent cause of elevat
academic.oup.com
Subclinical primary aldosteronism is an under-recognized driver of cardiovascular risk. Could it be a new target for CV prevention? Read our Circulation editorial —>
Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention? | Circulation
ahajournals.org
Jesslin Abraham, M.D.@jesslin23.bsky.social · 10mo agoSuch a great opportunity, to be involved in an editorial on the most recent evidence for Subclinical Primary Aldosteronism. Thank you to @drwanpen.bsky.social @giaconajohn.bsky.social Go check it out!! www.ahajournals.org/doi/10.1161/...
Our new study that links high Phosphate diet found in processed food and anxiety behavior and alternation of genes involved in mood regulation in mice. That may explain why we don't feel good after a whopper or a big Mac @hkkimphd.bsky.social @utswim.bsky.social sciencedirect.com/science/arti...
great HTN journal club discussing GWAS in primary aldosteronism by @jdmosley-moses.bsky.social @giaconajohn.bsky.social www.ahajournals.org/doi/10.1161/...
So much fun AHA #Hypertension25 gala dinner learning history of HTN from Bill Cushman and visiting with friends @anastasiasmihaili.bsky.social @giaconajohn.bsky.social @spjuraschek.bsky.social
@giaconajohn.bsky.social excellent talk highlights that intensive lowering of BP leads to lower not higher risk of OH based on metaanalysis of RCT by @spjuraschek.bsky.social #Hypertension25 Rx should be titrated to seated BP in OH as per 2025 high BP guidelines
Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled #Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial ca. 2025 from @asnpublications.bsky.social @escardio.bsky.social #Nephpearls #NephSky #ESCCongress 👉 journals.lww.com/jasn/fulltex...
Great dinner celebrating #Hypertension25 together near harbor with UTSW group Angie Price @giaconajohn.bsky.social @robynwei.bsky.social @jesslin23.bsky.social and Mu Huang
Dr Karol Watson starts with impactful message top 10 take away message #Hypertension25 high BP as predictor dementia and treatment reduces cognitive decline or dementia by 15% . Once you hit 120/80 , trajectory to high BP is steep. Don’t sit on high BP! @ahascience.bsky.social
Congratulations @robynwei.bsky.social RD/ PhD candidate for her poster #Hypertension25 highlighting underutilization of salt substitute use in the US @giaconajohn.bsky.social details in AHA News release newsroom.heart.org/news/u-s-sur... @ahascience.bsky.social
Honored to present my abstract poster at the AHA #hypertension25 on the prevalence of salt substitute use. Grateful that our work @drwanpen.bsky.social @giaconajohn.bsky.social @jesslin23.bsky.social was also featured in the official AHA news release: newsroom.heart.org/news/u-s-sur...
U.S. survey finds salt substitutes rarely used by people with high blood pressure
Research Highlights: Despite their effectiveness in lowering sodium intake and managing blood pressure, salt substitutes were rarely used by people with high blood pressure, according to a review of a...
newsroom.heart.org
Kicked off the day with a run around Baltimore Harbor 🌊🏃♂️ at #Hypertension25. A reminder that movement matters — let’s keep championing lifestyle and physical activity as powerful tools to reduce CVD and BP! @ahascience.bsky.social
Outstanding review of resistant hypertension at #HTN25 by Drs. @drwanpen.bsky.social , Keith Ferdinand, and Ty Gluckman — from current challenges in care to exciting new agents in the pipeline. Great insights into where the field is heading!
Thank you to AHA for the opportunity to present at AHA HTN scientific session 25 in Baltimore. Having an amazing time meeting and connecting with experts in the field! @drwanpen.bsky.social @giaconajohn.bsky.social @robynwei.bsky.social
Great talk #Hypertension25 by @jesslin23.bsky.social in discussing limitations of visual estimation of home BP in clinical decision in Rx HTN in Eyeball study @robynwei.bsky.social @giaconajohn.bsky.social
Fantastic opening session at AHA #HTN25 — great energy, insights, and inspiration already flowing. Excited for the great science and rich discussions ahead! @ahascience.bsky.social @drwanpen.bsky.social
Got to Baltimore #Hypertension25 so excited to see friends and colleagues talking about high BP ! @ahascience.bsky.social @giaconajohn.bsky.social
❓What’s new in BP care? 🎥 Watch the #TargetBP webinar on the 2025 @AHAScience / @ACCinTouch Hypertension Guidelines w/ @drwanpen.bsky.social , @jordybc.bsky.social , Keith Ferdinand, & Dan Jones 👉 targetbp.org
Join us @jordybc.bsky.social , Keith Ferdinand, and Dan Jones unpacking 2025 AHA/ACC guidelines on Thursday Aug 28 bit.ly/Guideline25W... @UTSWInternalMed @utswheart
New 2025 AHA/ACC Hypertension Guidelines are out! You will not want to miss this webinar! Sign up 👇
Wanpen Vongpatanasin@drwanpen.bsky.social · 12mo agoThe 2025 AHA/ACC Hypertension GL is out ! @CircAHA www.ahajournals.org/doi/10.1161/... please join us for the Targetbp Webinar as the first platform to digest the GL by @kcferdmd @jordybc.bsky.social and Dan Jones targetbp.org/events/ on August 28